can glp 1 cause vertigo The Risk of Vestibular Disorders with Semaglutide and Tirzepatide: Findings from a Large Real-World Cohort glp 1 dizzy spells Does

MIC is actually a combination of 3 non-vitamin compounds: Methionine, Inositol, and Choline Chloride

Cagrilintide vs semaglutide (Wegovy/Ozempic) Mechanism: Cagrilintide: Amylin receptor agonist Semaglutide: GLP-1 receptor agonist Different pathways Weight loss: Cagrilintide alone: 10-12% Semaglutide alone: 10-15% Similar efficacy monotherapy Gastric emptying: Cagrilintide: Very strong delay Semaglutide: Moderate delay Cagrilintide more powerful Side effects: Cagrilintide: More GI effects (stronger gastric slowing) Semaglutide: Moderate GI effects Cagrilintide harder to tolerate for some Availability: Cagrilintide: Investigational (not approved) Semaglutide: FDA approved, widely available Semaglutide easier to obtain currently Combination potential: Synergistic together (CagriSema) 15-25% weight loss combined Best of both mechanisms Verdict: Similar monotherapy efficacy, but combine for maximum results

Improved Blood Pressure and Cholesterol Levels In addition to their effects on blood glucose and weight, GLP-1 receptor agonists also contribute to improvements in blood pressure and lipid profiles, which can further reduce the risk of cardiovascular disease. Standard GLP-1 Dosing: What's Established Typical Doses The prescribed doses of GLP-1 receptor agonists are based on extensive clinical research and established therapeutic guidelines

Link to news story about the latest batch of warning letters in comments

Barroso-Sousa R, Barry WT, Garrido-Castro AC, et al